Prions: Protein Aggregation and Infectious Diseases - Physiological ...

213. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer
N, Waisman A, Rulicke T, Prinz M, Priller J, Becher
B, Aguzzi A. Experimental autoimmune encephalomyelitis repressed
by microglial paralysis. Nat Med 11: 146–152, 2005.
214. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, Oesch
B, Zinkernagel RM, Kalinke U, Aguzzi A. Prevention of scrapie
pathogenesis by transgenic expression of anti-prion protein antibodies.
Science 294: 178–182, 2001.
215. Heppner FL, Prinz M, Aguzzi A. Pathogenesis of prion diseases:
possible implications of microglial cells. Prog Brain Res 132: 737–
750, 2001.
216. Herland A, Nilsson KP, Olsson JD, Hammarstrom P, Konradsson
P, Inganas O. Synthesis of a regioregular zwitterionic conjugated
oligoelectrolyte, usable as an optical probe for detection of
amyloid fibril formation at acidic pH. J Am Chem Soc 127: 2317–
2323, 2005.
217. Hetz CA, Soto C. Stressing out the ER: a role of the unfolded
protein response in prion-related disorders. Curr Mol Med 6: 37–43,
2006.
218. Hill AF, Butterworth RJ, Joiner S, Jackson G, Rossor MN,
Thomas DJ, Frosh A, Tolley N, Bell JE, Spencer M, King A,
Al-Sarraj S, Ironside JW, Lantos PL, Collinge J. Investigation
of variant Creutzfeldt-Jakob disease and other human prion diseases
with tonsil biopsy samples. Lancet 353: 183–189, 1999.
219. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge
J, Doey LJ, Lantos P. The same prion strain causes vCJD
and BSE. Nature 389: 448–450, 1997.
220. Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A,
Poulter M, Wadsworth JD, Collinge J. Distinct glycoform ratios
of protease resistant prion protein associated with PRNP point
mutations. Brain 129: 676–685, 2006.
221. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new
variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349: 99,
1997.
222. Hilton DA. Pathogenesis and prevalence of variant Creutzfeldt-
Jakob disease. J Pathol 208: 134–141, 2006.
223. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J.
Prion immunoreactivity in appendix before clinical onset of variant
Creutzfeldt-Jakob disease. Lancet 352: 703–704, 1998.
224. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu
L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare
PD. The nature of small-airway obstruction in chronic obstructive
pulmonary disease. N Engl J Med 350: 2645–2653, 2004.
225. Holscher C, Delius H, Burkle A. Overexpression of nonconvertible
PrP C delta114-121 in scrapie-infected mouse neuroblastoma
cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation.
J Virol 72: 1153–1159, 1998.
226. Hope J, Reekie LJ, Hunter N, Multhaup G, Beyreuther K,
White H, Scott AC, Stack MJ, Dawson M, Wells GA. Fibrils
from brains of cows with new cattle disease contain scrapieassociated
protein. Nature 336: 390–392, 1988.
227. Horiuchi M, Caughey B. Specific binding of normal prion protein
to the scrapie form via a localized domain initiates its conversion to
the protease-resistant state. EMBO J 18: 3193–3203, 1999.
228. Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between
heterologous forms of prion protein: binding, inhibition of
conversion, and species barriers. Proc Natl Acad Sci USA 97:
5836–5841, 2000.
229. Hornemann S, Korth C, Oesch B, Riek R, Wider G, Wuthrich
K, Glockshuber R. Recombinant full-length murine prion protein,
mPrP(23-231): purification and spectroscopic characterization.
FEBS Lett 413: 277–281, 1997.
230. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger
JD, Westaway D, Ott J, Prusiner SB. Linkage of a prion protein
missense variant to Gerstmann-Sträussler syndrome. Nature 338:
342–345, 1989.
231. http://www.cjd.ed.ac.uk/figures.htm. Creutzfeldt-Jakob disease statistics
in the United Kingdom.
232. Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson
GG. Migrating intestinal dendritic cells transport PrP(Sc) from the
gut. J Gen Virol 83: 267–271, 2002.
AGGREGATION AND INFECTIOUS DISEASE 1145
Physiol Rev VOL 89 OCTOBER 2009 www.prv.org
233. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid:
a critical entity in the pathogenesis of type 2 diabetes. J Clin
Endocrinol Metab 89: 3629–3643, 2004.
234. Hutter G, Heppner FL, Aguzzi A. No superoxide dismutase
activity of cellular prion protein in vivo. Biol Chem 384: 1279–1285,
2003.
235. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl
J Med 357: 2153–2165, 2007.
236. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y.
Dissecting the pathological effects of human Abeta40 and Abeta42
in Drosophila: a potential model for Alzheimer’s disease. Proc Natl
Acad Sci USA 101: 6623–6628, 2004.
237. Immel F, Jiang Y, Wang Y, Marchal C, Maillet L, Perrett S,
Cullin C. In vitro analysis of SpUre2p, a prion-related protein,
exemplifies the relationship between amyloid and prion. J Biol
Chem 282: 7912–7920, 2007.
238. Jarrett JT, Lansbury PT Jr. Seeding “one-dimensional crystallization”
of amyloid: a pathogenic mechanism in Alzheimer’s disease
and scrapie? Cell 73: 1055–1058, 1993.
239. Jeffrey M, Goodsir CM, Bruce M, McBride PA, Scott JR,
Halliday WG. Correlative light and electron microscopy studies of
PrP localisation in 87V scrapie. Brain Res 656: 329–343, 1994.
240. Jimi T, Wakayama Y, Shibuya S, Nakata H, Tomaru T, Takahashi
Y, Kosaka K, Asano T, Kato K. High levels of nervous
system-specific proteins in cerebrospinal fluid in patients with
early stage Creutzfeldt-Jakob disease. Clin Chim Acta 211: 37–46,
1992.
241. Juanes ME, Elvira G, Garcia-Grande A, Calero M, Gasset M.
Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative
initiation of translation. J Biol Chem 284: 2787–2794, 2009.
242. Julius C, Heikenwalder M, Schwarz P, Marcel A, Karin M,
Prinz M, Pasparakis M, Aguzzi A. Prion propagation in mice
lacking central nervous system NF-kappaB signalling. J Gen Virol
89: 1545–1550, 2008.
243. Kaeser PS, Klein MA, Schwarz P, Aguzzi A. Efficient lymphoreticular
prion propagation requires PrP(c) in stromal and hematopoietic
cells. J Virol 75: 7097–7106, 2001.
244. Kaiserling E. Newly-formed lymph nodes in the submucosa in
chronic inflammatory bowel disease. Lymphology 34: 22–29, 2001.
245. Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt
C. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal
apoptosis. Proc Natl Acad Sci USA 96: 9409–9414, 1999.
246. Kane PM, Yamashiro CT, Wolczyk DF, Neff N, Goebl M,
Stevens TH. Protein splicing converts the yeast TFP1 gene product
to the 69-kD subunit of the vacuolar H -adenosine triphosphatase.
Science 250: 651–657, 1990.
247. Kanu N, Imokawa Y, Drechsel DN, Williamson RA, Birkett CR,
Bostock CJ, Brockes JP. Transfer of scrapie prion infectivity by
cell contact in culture. Curr Biol 12: 523–530, 2002.
249. Kao RR, Gravenor MB, Baylis M, Bostock CJ, Chihota CM,
Evans JC, Goldmann W, Smith AJ, McLean AR. The potential
size and duration of an epidemic of bovine spongiform encephalopathy
in British sheep. Science 295: 332–335, 2002.
250. Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Shultz LD,
Tew JG, Szakal AK. Follicular dendritic cell (FDC) precursors in
primary lymphoid tissues. J Immunol 160: 1078–1084, 1998.
251. Karin M. Nuclear factor-kappaB in cancer development and progression.
Nature 441: 431–436, 2006.
252. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC,
Cotman CW, Glabe CG. Common structure of soluble amyloid
oligomers implies common mechanism of pathogenesis. Science
300: 486–489, 2003.
253. Keller GA, Siegel MW, Caras IW. Endocytosis of glycophospholipid-anchored
and transmembrane forms of CD4 by different endocytic
pathways. EMBO J 11: 863–874, 1992.
254. Kerneis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion
by Peyer’s patch lymphocytes of human enterocytes into M
cells that transport bacteria. Science 277: 949–952, 1997.
255. Kim H, Chatani E, Goto Y, Paik S. Seed-dependent accelerated
fibrillation of alpha-synuclein induced by periodic ultrasonication
treatment. J Microbiol Biotechnol 17: 2027–2032, 2007.
256. Kim JI, Ju WK, Choi JH, Choi E, Carp RI, Wisniewski HM,
Kim YS. Expression of cytokine genes and increased nuclear fac-